Profile: Bioprocessing, Inc. is a manufacturer of specialized raw materials for use in the diagnostic industry. Our product line includes novel tumor marker antigens, tumor sell line pellets, custom control serum, acute phase protein antigens. The tumor market antigens are breast tumor, gastro intestinal, ovarian tumor, alpha fetoprotein, carcinoembryonic antigen, TAG72-4, cytokeratin-19, prostate specific, tissue polypeptide and ferritin antigen. Our breast tumor antigen is a glycoprotein that occurs in the alveoli and ducts of mammary glands, and it also exists as a circulating antigen. The custom control sera are multi-analyte tumor marker controls, C-reactive protein, rheumatoid factor and custom diluents.
The company was founded in 1991, has revenues of USD 1-5 Million, has ~50 employees and is ISO 9001 certified.
4 Products/Services (Click for related suppliers)
|
• Custom Control Serums |
• Multi Analyte Control (FDA Code: JJY / 862.1660) A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls. |
• Tumor Cell Line Pallets |
• Tumor Markers |